Hormone Replacement Therapy in Postmenopausal Women: Urinary N-Telopeptide of Type I Collagen Monitors Therapeutic Effect and Predicts Response of Bone Mineral Density
Authors:
- 1 January 1997
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 102 (1) , 29-37
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Urinary N-Telopeptides to Monitor Bone Resorption While on GnRH Agonist TherapyObstetrics & Gynecology, 1996
- Medical Treatment Of OsteoporosisPhysical Medicine and Rehabilitation Clinics of North America, 1995
- Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urineJournal of Bone and Mineral Research, 1994
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- The Prevention and Treatment of OsteoporosisNew England Journal of Medicine, 1992
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Long-Term Estrogen Replacement Therapy Prevents Bone Loss and FracturesAnnals of Internal Medicine, 1985
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980